Comparative phenotypic analysis of articular chondrocytes cultured within type i or type II collagen scaffolds

Tissue Engineering - Part A

Volumn 15, Issue 6, 2009, Pages 1233-1245

  Freyria, Anne Marie ^a,d   Ronzière, Marie Claire ^a   Cortial, Delphine ^a   Galois, Laurent ^b   Hartmann, Daniel ^c   Herbage, Daniel ^a   Mallein Gerin, Frédéric ^a  

^a University Lyon i   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ LYON 1   (France)

^d INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARTILAGE; CELL CULTURE; CROSSLINKING; GELATION; GELS; GENE EXPRESSION; LIGAMENTS; SCAFFOLDS; TISSUE ENGINEERING;

ARTICULAR CHONDROCYTES; ATELOCOLLAGEN; BOVINE ARTICULAR CHONDROCYTES; CHONDROCYTE; CHONDROCYTES; COLLAGEN SCAFFOLDS; CROSSLINKED; FLOATING CONDITIONS; GLYCOSAMINOGLYCAN; HIGH CELL DENSITY; IN-CELL; INTEGRIN; MATRIX METALLOPROTEINASE; PHENOTYPIC ANALYSIS; PROTEOGLYCAN; REAL-TIME POLYMERASE CHAIN REACTION; REPAIR STRATEGY; TYPE I COLLAGEN; TYPE II; TYPE II COLLAGENS;

COLLAGEN;

ALPHA INTEGRIN; ALPHA10 INTEGRIN; ALPHA11 INTEGRIN; ATELOCOLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGENASE 3; GLYCOSAMINOGLYCAN; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROTEOGLYCAN; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALF (BOVINE); CARTILAGE CELL; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

BOVINAE;

EID: 66249112161     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0114     Document Type: Article

References (59)

1. Galois, L., Freyria, A.M., Herbage, D., and Mainard, D. Ingenierie tissulaire du cartilage: etat des lieux et perspectives. Pathologie Biologie 53, 590, 2005.
2. Hunziker, E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10, 432, 2002.
3. Redman, S.N., Oldfield, S.F., and Archer, C.W. Current strategies for articular cartilage repair. Eur Cell Mater 9, 23, 2005.
4. Smith, G.D., Knutsen, G., and Richardson, J.B. A clinical review of cartilage repair techniques. J Bone Joint Surg 87-B, 445, 2005.
5. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994.
6. Lindahl, A., Brittberg, M., and Peterson, L. Cartilage repair with chondrocytes: clinical and cellular aspects. Novartis Found Symp 249, 175, 2003.
7. Mandelbaum, B., Browne, J.E., Fu, F., Micheli, L.J., Moseley, J.B., Jr., Erggelet, C., and Anderson, A.F. Treatment outcomes of autologous chondrocyte implantation for full-thickness articular cartilage defects of the trochlea. Am J Sports Med 35, 915, 2007.
8. Micheli, L.J., Moseley, J.B., Anderson, A.F., Browne, J.E., Erggelet, C., Arciero, R., Fu, F.H., and Mandelbaum, B.R. Articular cartilage defects of the distal femur in children and adolescents: treatment with autologous chondrocyte implantation. J Pediatr Orthop 26, 455, 2006.
9. Wasiak, J., Clar, C., and Villanueva, E. Autologous cartilage implantation for full thickness articular cartilage defects of the knee. Cochrane Database Syst Rev 3, CD003323, 2006.
10. Knutsen, G., Drogset, J.O., Engebretsen, L., Grontvedt, T., Isaksen, V., Ludvigsen, T.C., Roberts, S., Solheim, E., Strand, T., and Johansen, O. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am 89, 2105, 2007.
11. Cancedda, R., Dozin, B., Giannoni, P., and Quarto, R. Tissue engineering and cell therapy of cartilage and bone. Matrix Biol 22, 81, 2003.
12. Marlovits, S., Zeller, P., Singer, P., Resinger, C., and Vecsei, V. Cartilage repair: generations of autologous chondrocyte transplantation. Eur J Radiol 57, 24, 2006.
13. Nesic, D., Whiteside, R., Brittberg, M., Wendt, D., Martin, I., and Mainil-Varlet, P. Cartilage tissue engineering for degenerative joint disease. Adv Drug Delivery Rev 58, 300, 2006.
14. Temenoff, J.S., and Mikos, A.G. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 21, 431, 2000.
15. Russlies, M., Behrens, P., Wunsch, L., Gille, J., and Ehlers, E.M. A cell-seeded biocomposite for cartilage repair. Ann Anat 184, 317, 2002.
16. Steinwachs, M., and Kreuz, P.C. Autologous chondrocyte implantation in chondral defects of the knee with a type I/III collagen membrane: a prospective study with a 3-year follow-up. Arthroscopy 23, 381, 2007.
17. Ochi, M., Uchio, Y., Kawasaki, K., Wakitani, S., and Iwasa, J. Transplantation of cartilage-like tissue made by tissue engineering in the treatment of cartilage defects of the knee. J Bone Joint Surg Br 84, 571, 2002.
18. Andereya, S., Maus, U., Gavenis, K., Muller-Rath, R., Miltner, O., Mumme, T., and Schneider, U. [First clinical experiences with a novel 3D-collagen gel (CaReS) for the treatment of focal cartilage defects in the knee]. Z Orthop Ihre Grenzgeb 144, 272, 2006.
19. Wakitani, S., Imoto, K., Yamamoto, T., Saito, M., Murata, N., and Yoneda, M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10, 199, 2002.
20. Bajtner, E., Nandakumar, K.S., Engstrom, A., and Holmdahl, R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther 7, R1148, 2005.
21. Malemud, C.J., Stevenson, S., Mehraban, F., Papay, R.S., Purchio, A.F., and Goldberg, V.M. The proteoglycan synthesis repertoire of rabbit chondrocytes maintained in type II collagen gels. Osteoarthritis Cartilage 2, 29, 1994.
22. Mukaida, T., Urabe, K., Naruse, K., Aikawa, J., Katano, M., Hyon, S.H., and Itoman, M. Influence of three-dimensional culture in a type II collagen sponge on primary cultured and dedifferentiated chondrocytes. J Orthop Sci 10, 521, 2005.
23. Nehrer, S., Breinan, H.H., Ashkar, S., Shortkroff, S., Minas, T., Sledge, C.B., Yannas, I.V., and Spector, M. Characteristics of articular chondrocytes seeded in collagen matrices in vitro. Tissue Eng 4, 175, 1998.
24. Pieper, J.S., van der Kraan, P.M., Hafmans, T., Kamp, J., Buma, P., van Susante, J.L., van den Berg, W.B., Veerkamp, J.H., and van Kuppevelt, T.H. Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering. Biomaterials 23, 3183, 2002.
25. Lee, C.R., Breinan, H.A., Nehrer, S., and Spector, M. Articular cartilage chondrocytes in type I and type II collagen-GAG matrices exhibit contractile behavior in vitro. Tissue Eng 6, 555, 2000.
26. Nehrer, S., Breinan, H.A., Ramappa, A., Shortkroff, S., Young, G., Minas, T., Sledge, C.B., Yannas, I.V., and Spector, M. Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res 38, 95, 1997.
27. Farjanel, J., Schurmann, G., and Bruckner, P. Contacts with fibrils containing collagen I, but not collagens II, IX, and XI, can destabilize the cartilage phenotype of chondrocytes. Osteoarthritis Cartilage 9 Suppl A, S55, 2001.
28. Vogel, W.F., Abdulhussein, R., and Ford, C.E. Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal 18, 1108, 2006.
29. Xu, L., Peng, H., Wu, D., Hu, K., Goldring, M.B., Olsen, B.R., and Li, Y. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem 280, 548, 2005.
30. Heckmann, L., Fiedler, J., Mattes, T., and Brenner, R.E. Mesenchymal progenitor cells communicate via alpha and beta integrins with a three-dimensional collagen type I matrix. Cells Tissues Organs 182, 143, 2006.
31. Langholz, O., Rockel, D., Mauch, C., Kozlowska, E., Bank, I., Krieg, T., and Eckes, B. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J Cell Biol 131, 1903, 1995.
32. Ravanti, L., Heino, J., Lopez-Otin, C., and Kahari, V.M. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 274, 2446, 1999.
33. Riikonen, T., Koivisto, L., Vihinen, P., and Heino, J. Transforming growth factor-beta regulates collagen gel contraction by increasing alpha 2 beta 1 integrin expression in osteogenic cells. J Biol Chem 270, 376, 1995.
34. Ronziere, M.C., Aubert-Foucher, E., Gouttenoire, J., Bernaud, J., Herbage, D., and Mallein-Gerin, F. Integrin alpha1beta1 mediates collagen induction of MMP-13 expression in MC615 chondrocytes. Biochim Biophys Acta 1746, 55, 2005.
35. Tiger, C.F., Fougerousse, F., Grundstrom, G., Velling, T., and Gullberg, D. Alpha11beta1 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev Biol 237, 116, 2001.
36. Galois, L., Hutasse, S., Cortial, D., Rousseau, C.F., Grossin, L., Ronziere, M.C., Herbage, D., and Freyria, A.M. Bovine chondrocyte behaviour in three-dimensional type I collagen gel in terms of gel contraction, proliferation and gene expression. Biomaterials 27, 79, 2006.
37. Le Guellec, D., Mallein-Gerin, F., Treilleux, I., Bonaventure, J., Peysson, P., and Herbage, D. Localization of the expression of type I, II and III collagen genes in human normal and hypochondrogenesis cartilage canals. Histochem J 26, 695, 1994.
38. Mallein-Gerin, F. Sub epithelial type II collagen deposition during embryonic chick limb development Roux Arch Dev Biol 198, 363, 1990.
39. Cortial, D., Gouttenoire, J., Rousseau, C.F., Ronziere, M.C., Piccardi, N., Msika, P., Herbage, D., Mallein-Gerin, F., and Freyria, A.M. Activation by IL-1 of bovine articular chondrocytes in culture within a 3D collagen-based scaffold. An in vitro model to address the effect of compounds with therapeutic potential in osteoarthritis. Osteoarthritis Cartilage 14, 631, 2006.
40. Freyria, A.M., Yang, Y., Chajra, H., Rousseau, C.F., Ronziere, M.C., Herbage, D., and El Haj, A.J. Optimization of dynamic culture conditions: effects on biosynthetic activities of chondrocytes grown in collagen sponges. Tissue Eng 11, 674, 2005.
41. Roche, S., Ronziere, M.C., Herbage, D., and Freyria, A.M. Native and DPPA cross-linked collagen sponges seeded with fetal bovine epiphyseal chondrocytes used for cartilage tissue engineering. Biomaterials 22, 9, 2001.
42. Lee-Own, V., and Anderson, J.C. Interaction between proteoglycan subunit and type II collagen from bovine nasal cartilage, and the preferential binding of proteoglycan sub-unit to type I collagen. Biochem J 153, 259, 1976.
43. Pieper, J.S., Hafmans, T., Veerkamp, J.H., and van Kuppevelt, T.H. Development of tailor-made collagen-glycosaminoglycan matrices: EDC/NHS crosslinking, and ultrastructural aspects. Biomaterials 21, 581, 2000.
44. Freyria, A.-M., Cortial, D., Ronziere, M.-C., Guerret, S., and Herbage, D. Influence of medium composition, static and stirred conditions on the proliferation of and matrix protein expression of bovine articular chondrocytes cultured in a 3-D collagen scaffold. Biomaterials 25, 687-697, 2004.
45. Bluteau, G., Gouttenoire, J., Conrozier, T., Mathieu, P., Vignon, E., Richard, M., Herbage, D., and Mallein-Gerin, F. Differential gene expression analysis in a rabbit model of osteoarthritis induced by anterior cruciate ligament (ACL) section. Biorheology 39, 247, 2002.
46. Ronziere, M.C., Roche, S., Gouttenoire, J., Demarteau, O., Herbage, D., and Freyria, A.M. Ascorbate modulation of bovine chondrocyte growth, matrix protein gene expression and synthesis in three-dimensional collagen sponges. Biomaterials 24, 851, 2003.
47. Lamar, C.H., van Sickle, D.C., Brandman, P., and Hinsman, E.J. Ultrastructure of timed isolates of in vitro canine articular chondrocytes. Am J Vet Res 41, 241, 1980.
48. Gavénis, K., Schmidt-Rohlfing, B., Mueller-Rath, R., Andereya, S., and Schneider, U. In vitro comparison of six different matrix systems for the cultivation of human chondrocytes. In Vitro Cell Dev Biol Anim 42, 159, 2006.
49. Benya, P.D., Padilla, S.R., and Nimni, M.E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15, 1313, 1978.
50. Leddy, H.A., Awad, H.A., and Guilak, F. Molecular diffusion in tissue-engineered cartilage constructs: effects of scaffold material, time, and culture conditions. J Biomed Mater Res B Appl Biomater 70, 397, 2004.
51. Hu, K., Xu, L., Cao, L., Flahiff, C.M., Brussiau, J., Ho, K., Setton, L.A., Youn, I., Guilak, F., Olsen, B.R., and Li, Y. Pathogenesis of osteoarthritis-like changes in the joints of mice deficient in type IX collagen. Arthritis Rheum 54, 2891, 2006.
52. Vonk, L.A., Zandieh Doulabi, B., Huang, C.L., Kroeze, R.J., Helder, M.N., and Bank, R.A. Chondrocytes isolated from different cartilage tissues show different gene expression patterns. Presented at the TERMIS-EU Meeting, London, UK, 2007. Abstract no. 64.
53. Yates, K.E., Allemann, F., and Glowacki, J. Phenotypic analysis of bovine chondrocytes cultured in 3D collagen sponges: effect of serum substitutes. Cell Tissue Bank 6, 45, 2005.
54. Chaipinyo, K., Oakes, B.W., and van Damme, M.P. The use of debrided human articular cartilage for autologous chondrocyte implantation: maintenance of chondrocyte differentiation and proliferation in type I collagen gels. J Orthop Res 22, 446, 2004.
55. Kino-Oka, M., Yashiki, S., Ota, Y., Mushiaki, Y., Sugawara, K., Yamamoto, T., Takezawa, T., and Taya, M. Subculture of chondrocytes on a collagen type I-coated substrate with suppressed cellular dedifferentiation. Tissue Eng 11, 597, 2005.
56. Takahashi, T., Ogasawara, T., Asawa, Y., Mori, Y., Uchinuma, E., Takato, T., and Hoshi, K. Three-dimensional microenvironments retain chondrocyte phenotypes during proliferation culture. Tissue Eng 13, 1583, 2007.
57. Valcourt, U., Gouttenoire, J., Aubert-Foucher, E., Herbage, D., and Mallein-Gerin, F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett 545, 115, 2003.
58. Valcourt, U., Gouttenoire, J., Moustakas, A., Herbage, D., and Mallein-Gerin, F. Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes. J Biol Chem 277, 33545, 2002.
59. Hautier, A., Salentey, V., Aubert-Foucher, E., Bougault, C., Beauchef, G., Ronziere, M.-C., de Sobranitsky, S., Paumier, A., Galéra, P., Piperno, M., Damour, O., and Mallein-Gerin, F. Bone morphogenetic protein-2 stimulates chondrogenic expression in human nasal chondrocytes expanded in vitro. Growth Factors 26, 201, 2008.